Comments
Drug firm Dr Reddy’s Laboratories Inc is recalling over 3.25 lakh cartons of Zenatane (isotretinoin) capsules, used for the treatment of severe acne, from the US market due to failed dissolution specifications.
The drug is manufactured by pharma firm Cipla at its Pune facility for Dr Reddy’s Laboratories .
While 13,221 cartons of the capsules in 10 mg strength are being recalled by the company, it is removing 89,118 cartons in 20 mg strength and 2,23,650 cartons in 30 mg, the latest Enforcement Report of the USFDA said.
The product in the three strengths is being recalled due to “Failed Dissolution Specifications: out of specification results observed for low dissolution,” it added.
The ongoing voluntary class II recall is nationwide in the US and Puerto Rico, the United States Food and Drug Administration (USFDA) said.
Zenatane is indicated for the treatment of severe recalcitrant nodular acne.
According to FDA, a class II recall is initiated in a “situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote”.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.